NEW YORK, Dec 12 - Bio-Rad Laboratories and Luminex said Tuesday they had entered into an agreement to jointly commercialize a system for drug discovery applications based on Luminex's LabMAP technology.

Bio-Rad has incorporated Luminex's microsphere-based assay technology and reader into its Bio-Plex Protein Array System. The new product, which will be available in the first quarter of 2001, is the outcome of a two-year collaboration between the companies.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

An opinion piece in the Guardian argues that President Donald Trump is uninterested in science and that might not be a bad thing for the field.

Stat News reports that Spark Therapeutics' Luxturna is now being used to treat a wider array of patients.

The San Francisco Chronicle reports the Veterans Affairs Health System is studying whether genetic testing can help prescribe better depression therapies.

In Genome Biology this week: transcription factor use among brittle stars, single-cell RNA sequencing strategy, and more.